Motor Impairments in Children With Autism Spectrum Disorder: a Multimodal Approach (MOSAICO)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04769011 |
Recruitment Status :
Completed
First Posted : February 24, 2021
Last Update Posted : March 28, 2024
|
Sponsor:
IRCCS Eugenio Medea
Information provided by (Responsible Party):
IRCCS Eugenio Medea
Tracking Information | |||||
---|---|---|---|---|---|
First Submitted Date ICMJE | February 11, 2021 | ||||
First Posted Date ICMJE | February 24, 2021 | ||||
Last Update Posted Date | March 28, 2024 | ||||
Actual Study Start Date ICMJE | January 2, 2018 | ||||
Actual Primary Completion Date | December 31, 2023 (Final data collection date for primary outcome measure) | ||||
Current Primary Outcome Measures ICMJE |
|
||||
Original Primary Outcome Measures ICMJE | Same as current | ||||
Change History | |||||
Current Secondary Outcome Measures ICMJE | Not Provided | ||||
Original Secondary Outcome Measures ICMJE | Not Provided | ||||
Current Other Pre-specified Outcome Measures | Not Provided | ||||
Original Other Pre-specified Outcome Measures | Not Provided | ||||
Descriptive Information | |||||
Brief Title ICMJE | Motor Impairments in Children With Autism Spectrum Disorder: a Multimodal Approach | ||||
Official Title ICMJE | Motor Impairments in Children With Autism Spectrum Disorder: a Multimodal Approach | ||||
Brief Summary | The general goal of the present proposal, Progetto MOSAICO, is the identification of a multimodal panel of neuropsychological, kinematic, neurophysiological, and genetic markers associated with motor abnormalities present in ASD. | ||||
Detailed Description | Not Provided | ||||
Study Type ICMJE | Interventional | ||||
Study Phase ICMJE | Not Applicable | ||||
Study Design ICMJE | Allocation: N/A Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Diagnostic |
||||
Condition ICMJE |
|
||||
Intervention ICMJE |
|
||||
Study Arms ICMJE | Experimental: Clinical, neuropsychological, neurophysiological, and genetic evaluations
Clinical, neuropsychological, neurophysiological, and genetic evaluations
Interventions:
|
||||
Publications * | Not Provided | ||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
Recruitment Information | |||||
Recruitment Status ICMJE | Completed | ||||
Actual Enrollment ICMJE |
106 | ||||
Original Estimated Enrollment ICMJE |
80 | ||||
Actual Study Completion Date ICMJE | December 31, 2023 | ||||
Actual Primary Completion Date | December 31, 2023 (Final data collection date for primary outcome measure) | ||||
Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||
Sex/Gender ICMJE |
|
||||
Ages ICMJE | 1 Year to 14 Years (Child) | ||||
Accepts Healthy Volunteers ICMJE | Yes | ||||
Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||
Listed Location Countries ICMJE | Italy | ||||
Removed Location Countries | |||||
Administrative Information | |||||
NCT Number ICMJE | NCT04769011 | ||||
Other Study ID Numbers ICMJE | 510 | ||||
Has Data Monitoring Committee | No | ||||
U.S. FDA-regulated Product |
|
||||
IPD Sharing Statement ICMJE |
|
||||
Current Responsible Party | IRCCS Eugenio Medea | ||||
Original Responsible Party | Same as current | ||||
Current Study Sponsor ICMJE | IRCCS Eugenio Medea | ||||
Original Study Sponsor ICMJE | Same as current | ||||
Collaborators ICMJE | Not Provided | ||||
Investigators ICMJE | Not Provided | ||||
PRS Account | IRCCS Eugenio Medea | ||||
Verification Date | March 2024 | ||||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |